Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: chronic pain

Coding Corner Answer

From the College  |  November 1, 2010

November’s Coding Answer

Filed under:Billing/CodingFrom the CollegePractice Support Tagged with:BillingCodingPQRIRheumatoid arthritis

No Clear Connection Between Inflammation & Disease Progression in AS

Kathy Holliman  |  October 1, 2010

TNF blockers decrease symptoms but seem to have little impact on structural damage

Filed under:Axial SpondyloarthritisConditionsOther Rheumatic ConditionsRheumatoid Arthritis Tagged with:Ankylosing SpondylitisinflammationRARheumatoid arthritistherapytumor necrosis factor

Ethics Forum: Understanding the Challenges in Rheumatology Today

C. Ronald MacKenzie, MD, Elizabeth, Kitsis, MD, MBE, and Michele Meltzer, MD, MBE  |  October 1, 2010

Understanding the challenges in rheumatology today

Filed under:EthicsProfessional Topics Tagged with:Back painEthicsGuidelinesPatientsQuality

National Academy of Sciences Elects Three Rheumatologists

Kurt Ullman  |  August 1, 2010

First time three people from the specialty selected in the same year

Filed under:Profiles Tagged with:AwardsNASNational Academy of SciencesTNF

The Expanded Role of the Inflammasome in Human Disease

Alexander So, MD, and Borbála Pazár, MD, PhD  |  August 1, 2010

Exploring advances, evaluating what remains to be done

Filed under:ConditionsOther Rheumatic Conditions Tagged with:autoinflammatoryInflammasomeinflammationinflammatory syndromesInterleukinSchnitzler’s syndrome

Drug Updates

From the College  |  July 1, 2010

Information on New Approvals and Medication Safety

Filed under:Drug UpdatesFrom the College Tagged with:ApprovalsBiologicsJuvenile arthritisPipline

Rheumatology and the Patient-Centered Home

J. Timothy Harrington, MD, and Eric D. Newman, MD  |  July 1, 2010

Is it the end of the tunnel or an oncoming train?

Filed under:Practice Support Tagged with:Centers for Medicare & Medicaid Services (CMS)Chronic disease managementMedical HomePrimary Care Physician

Tracking Patient Manifestations of Behçet’s Syndrome around the World

Yusuf Yazici, MD  |  July 1, 2010

Tracking patient manifestations of Behçet’s syndrome around the world

Filed under:Clinical Criteria/GuidelinesConditions Tagged with:Behçet’s diseaseDiagnostic CriteriaPathogenesisTreatment

Cobra Therapy for Rheumatoid Arthritis

Lilian H.D. van Tuyl, PhD, and Maarten Boers, MD, PhD  |  June 1, 2010

Initial high-dose therapy may help patients seeking relief

Filed under:ConditionsRheumatoid Arthritis Tagged with:Cobra TherapyDisease-modifying antirheumatic drugs (DMARDs)prednisoloneRheumatoid arthritisTreatment

Within Our Reach–Funded Study Finds Increased Depression Risk Among Some RA Patients

From the College  |  May 1, 2010

A study recently published in Arthritis & Rheumatism found that a cohort of patients from multiethnic backgrounds who all had rheumatoid arthritis (RA) had nearly double the rate of depressive symptoms compared with middle-class white patients with RA.1 The study also examined predictors of depression, and concluded that physical disability—not acute disease activity—is the principal predictor of depression in patients with RA.

Filed under:ConditionsFrom the CollegeResearch RheumRheumatoid Arthritis Tagged with:Clinical researchDepressionREF NewsRheumatoid arthritis

  • « Previous Page
  • 1
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 106
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences